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The profession was connected closely with the men' s population.
Because of the frequency of illness (1-36/100.000) in the Mediter-
ranean region the brucellosis should always be considered in the
differential diagnosis of prolonged fever.
106
Intravascular Device-related Infections in Neurosurgical
Patients: Incidence and Predictors
Nikolaos Syrmos, Vasilios Valadakis, Konstantinos Grigoriou,
Stefanos Patiakas, Dimitrios Arvanitakis. Neurosurgical
Department, Venizeleio General Hospital, Heraklion, Crete,
Greece
Introduction: The rate intravascular device-related infection
varies widely depending most of the times in factors such as- the
nature of the procedure, the patient' s diagnosis, the patient sta-
tus, the nursing comorbidities and other risk factors.
Objective: The objective of our study was to find the frequency
of the colonization of intravascular catheters in neurosurgical pa-
tients.
Materials and Methods: During a five-year period (2002-2007) cul-
tures of the cotton swabs and tips of 150 catheters were done by
qualitative and semiquantitative methods.
Results: The mean colonization rate of the catheter tips was 15,
5%. The most frequent isolates were Gram-positive Staphylococcus
aureus, Staphylococcus epidermidis, CNS etc and Gram-negative
Pseudomonas aeruginosa, Acinetobacter baumanni, etc.
Conclusions: Intravascular catheters are frequently colonized.
These types of infections are a major problem in neurosurgical pa-
tients' . The collaboration between neurosurgeons and laboratory
medical staff is necessary for the best final result.
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Introduction: The increasing resistance of fungal strains to anti-
fungal agents is the main reason of research on the new antifun-
gals.
Objectives: The susceptibility analysis of fungal strain isolated
from patients hospitalized in Warsaw Medical University Central
Clinical Hospital in 2007 to Posaconazole in vitro.
Materials and Methods: The clinical material was consisted of:
blood samples 33 (43.4%), respiratory tracts specimens (23.7%),
wound swabs 16 (21%), urine samples 4 (5.3%) and other 5 (6.6%).
Strains were cultured on Sabouraud and CHROMagar media and
identify by ID32C tests. The susceptibility analysis to Posaconazole
was done according to E-tests.
Results: From the total number of 76 positive samples we cultured
87 of fungal strains. The following species were cultured C. gal-
brata 41 (47%), C. albicans 12 (14%), C. krusi 10 (11.5%), C. para-
psilosis 6 (7%), C. inconspicua 4 (4.5%), Saccharomyces cerevisiae
4 (4.5%), other 10 (11.5%). We isolated 83 strains of the yeast like
fungi (95% out of all isolates) and two species of molds (5% of all
isolates): Aspergillus fumigatus 2 strains and Fusarium incarnatum
2. Our results were analyzed according to ARTEMIS Program. The fi-
nal Posaconazole concentration was 0,008 to 32ug/ml. In our study
the break point was 1 ug/ml and it was established as the agent
activity. Posaconazole was active for 83 isolates (95% casus) and it
had the break point 1 ug/ml. The all resistant isolates were from
the same species of C. glabrata. Posaconazole had not been active
for 4 (5%) of isolates.
Conclusions: 10% of C. glabrata isolates were Posaconazole resis-
tant. Posaconazole was active for 95% of isolated strains.
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Background: The incidence of invasive fungal infections increases
worldwide, and rare fungi - neither belonging to the genera As-
pergillus, Candida, Pneumocystis or Cryptococcus, nor being en-
demic, is increasingly identified as causative pathogens.
Methods: We are coordinating a global registry for cases of rare
invasive fungi. Our objective is to broaden the knowledge on epi-
demiology, to determine the clinical pattern of disease, to describe
and improve diagnostic procedures and therapeutic regimens, as
well as to facilitate exchange of clinical isolates among the con-
tributors. Entry of retrospective data occurs via a web-based regis-
tration system (MACRO) that focuses on demographic information,
underlying diseases, risk factors, details on the infection, therapy
and outcome. Inclusion criteria include cultural, histopathological,
antigen, or DNA evidence of invasive fungal infection. Infection
due to Aspergillus spp., Candida spp., Cryptococcus neoformans,
Pneumocystis jiroveci or any endemic fungal infection, as well as
mere colonization or other non-invasive infections are exclusion
criteria. For evaluable patient documentations, authorship posi-
tions in resulting publications will be available and a compensation
of €100 each will be paid. If the documentation workload is too
high, centers are encouraged to ask the study office for personnel
to be sent to the site. For isolates made available to the central
laboratory an additional €50 will be paid. Plasma levels of all com-
mon antifungals can be determined from serum, liquor, and other
tissue samples. This service is provided for free to all participating
investigators.
Results: By now, 20 cases of rare invasive fungal infections
have been identified, including Mucoclades corymbifera, Cunning-
hamella bertholletiae, Penicillium marneffei, Rhizomucor pusil-
lus, as well as Acremonium spp., Fusarium spp., Coccidioides spp.,
and Trichoderma spp. Clinical results are partly pending. Most pa-
tients were in an immunocompromised state as a result of their
underlying disease, chemotherapy or transplantation.
Discussion: The clinical relevance of invasive fungal infections by
rare fungi is increasing steadily. In a short period of time, actual
cases from Germany, Austria, Italy and the United Kingdom could
be documented, showing the broad spectrum of pathogens. Further
investigators and coordinators are cordially invited to contribute to
the success of Fungiscope.
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Background: Cryptococcosis is rare and occurs mainly in immuno-
